Skip to content Synspira
Synspira Mobile Menu Toggle navigation
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Pulmonary
      Disease
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact
  • About
    • Who We Are
    • Our Focus
    • Leadership
    • Board
      of Directors
  • Therapeutic Areas
    • Pulmonary
      Disease
  • Product Development
  • News & Publications
    • Press Releases
    • Publications
      & Abstracts
  • Contact

Category: Presentations

In vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus

Posted on August 3, 2018May 11, 2023 by Kathryn Kilroy
Posted in Presentations

Novel glycopolymer eradicates antibiotic- and CCCP- induced persister cells in Pseudomonas aeruginosa

Posted on January 17, 2018May 11, 2023 by Kathryn Kilroy
Posted in Presentations

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem

Posted on June 29, 2017May 11, 2023 by Kathryn Kilroy
Posted in Presentations
  • Privacy Policy
  • Terms & Conditions
  • FCOI Policy

©2025 Synspire Pharmaceuticals, Inc.

All Rights Reserved.